Janosch Railton

Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine

S. Barruscotti, E. Isoletta, M. Volonté, 2024, Frontiers in immunology.